# Kovai Medical Center & Hospital share price today (Kovai Medical Center & Hospital Ltd, NSE: KOVAI)

> Kovai Medical Center & Hospital share price today: ₹5,887.50 at the NSE close on 3 November 2026, down 8.0% in a year. Kovai Medical Center & Hospital (NSE: KOVAI) is worth ₹6,441 crore, trades at a P/E of 25.1 and has closed between ₹5,097.95 and ₹6,232.60 over the past 52 weeks. > Kovai Medical Center & Hospital Ltd's earnings have grown faster than its share price. Earnings per share grew +17.0% in a year while the price moved −8.0%. KOVAI · Hospitals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/kovai-medical-center-hospital-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Growing steadily, from the last 12 quarters
- Price: ₹5,887.50 (−8.0% in a year)
- P/E: 25.1× (higher than 73% of the last 11 years)
- Revenue (Jun 2026): ₹431 Cr (+15.2% on a year ago)
- Profit (Jun 2026): ₹69.0 Cr (+21.1% on a year ago)
- Operating margin: 29.0% (+1.0 points on a year ago)
- ROCE: 23%, FY26
- ROIC: 18.9%, against a 12.0% cost of capital: +6.9 points

The main question: yearly earnings per share moved +17.0% while the share price moved −8.0%. ## What is the Kovai Medical Center & Hospital share price today? Kovai Medical Center & Hospital Ltd's share price was ₹5,887.50 at the close on 3 November 2026. It has been rising for 16 weeks. That is 1.0% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹5,098 and ₹6,233, and at that close it sat 70% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 11 weeks in a row. Over the last 11 years the share price moved +800% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Kovai Medical Center & Hospital this quarter? Three changes stood out: revenue up on a year earlier for 11 quarters in a row (every quarter we can compare), profit up on a year earlier for 11 quarters in a row (every quarter we can compare) and highest quarterly profit in 15 quarters. 1. Revenue up on a year earlier for 11 quarters in a row (every quarter we can compare) In the June 2026 quarter revenue was ₹431 crore, +15.2% on a year earlier. 2. Profit up on a year earlier for 11 quarters in a row (every quarter we can compare) In the June 2026 quarter profit was ₹69 crore, +21.1% on a year earlier. 3. Highest quarterly profit in 15 quarters Profit of ₹69 crore in the June 2026 quarter is the highest of the last 15 quarters. ## What are Kovai Medical Center & Hospital's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Kovai Medical Center & Hospital reported revenue of ₹431 crore, up 15.2% from ₹374 crore a year earlier, and a profit of ₹69.0 crore, up 21.1% from ₹57.0 crore. ### Kovai Medical Center & Hospital results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹431 crore | ₹374 crore | +15.2% |
| Profit | ₹69.0 crore | ₹57.0 crore | +21.1% |
| Earnings per share | ₹63.14 | ₹52.30 | +20.7% |
| Operating margin | 29.0% | 28.0% | +1.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Kovai Medical Center & Hospital share price history? Kovai Medical Center & Hospital closed at ₹5,887.50 on 3 November 2026, down 8.0% from ₹6,399.55 a year earlier (31 October 2025) and up 255.4% over five years. Its highest weekly close since March 2016 was ₹6,685.10 on 24 October 2025. ### Kovai Medical Center & Hospital share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹5,737.95 | +2.6% |
| 1 month ago · 1 Oct 2026 | ₹6,001.50 | −1.9% |
| 6 months ago · 30 Apr 2026 | ₹5,665.45 | +3.9% |
| 1 year ago · 31 Oct 2025 | ₹6,399.55 | −8.0% |
| 3 years ago · 3 Nov 2023 | ₹2,658.35 | +121.5% |
| 5 years ago · 4 Nov 2021 | ₹1,656.45 | +255.4% |
| 10 years ago · 4 Nov 2016 | ₹792.95 | +642.5% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹654.25 | +799.9% |
| Highest weekly close since March 2016 · 24 Oct 2025 | ₹6,685.10 | −11.9% |
| Lowest weekly close since March 2016 · 22 May 2020 | ₹575.00 | +923.9% |
| 52-week high (weekly close) · 18 Sep 2026 | ₹6,232.60 | −5.5% |
| 52-week low (weekly close) · 2 Apr 2026 | ₹5,097.95 | +15.5% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (562 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on Kovai Medical Center & Hospital? 3 Nov 2026: Kovai Medical Center & Hospital closed at ₹5,887.50, up 2.6% on the week and down 1.9% on the month. 19 Aug 2026: ex-date for a dividend of ₹15 a share. ### Earlier

- Results for April to June 2026: Revenue up 15.2% and profit up 21.1% on a year earlier. ## What dividend does Kovai Medical Center & Hospital pay? Kovai Medical Center & Hospital paid ₹15 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.25% at the ₹5,887.50 close on 3 November 2026. The last was a dividend of ₹15 a share, ex-date 19 August 2026. ### Kovai Medical Center & Hospital dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 19 Aug 2026 | ₹15 | Dividend |
| 11 Aug 2023 | ₹10 | Dividend + Special |
| 25 Aug 2022 | ₹6 | Dividend + Special |
| 2 Sep 2021 | ₹3 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 3 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Kovai Medical Center & Hospital Ltd paid out 7% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Kovai Medical Center & Hospital management say on the latest results call? Kovai Medical Center & Hospital's management made 0 promises we could check against what it later reported. (Our read after the April to June 2026 results, written 22 August 2026.)

## What is the future of Kovai Medical Center & Hospital? What is changing in the business? What is changing at Kovai Medical Center & Hospital, from the latest results and calls: tertiary care demand density in western tamil nadu, operating leverage from medical college and bed additions and self-funding expansion cash profile. - Tertiary Care Demand Density in Western Tamil Nadu. Regional dominance in Coimbatore drives inpatient volumes and surgical procedure mix across multi-specialty departments. ✓ fact
- Operating Leverage from Medical College and Bed Additions. Fixed medical infrastructure and teaching hospital assets convert incremental volume to profit at 27% to 29% operating margins. ✓ fact
- Self-Funding Expansion Cash Profile. 3-year cumulative operating cash flow of 1,041 Cr fully funds ongoing brownfield projects and allows debt reduction. ✓ fact
- Minimal Working Capital and Cash Collection Cycles. Debtor collection periods of 5 to 9 days keep the cash conversion cycle at 6 days, preventing capital lock-up. ✓ fact

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown. (Our read after the April to June 2026 results, written 22 August 2026.)

## What could change the Kovai Medical Center & Hospital story? What are the risks? A sustained deterioration in quarterly operating profit margin below 24% combined with debtor days expanding beyond 20 days or negative free cash flow for three consecutive quarters without planned capacity commissioning. ### Each change stops working if

- Tertiary Care Demand Density in Western Tamil Nadu: New corporate hospital chains construct competing tertiary facilities in Coimbatore and dilute local patient market share. - Operating Leverage from Medical College and Bed Additions: Clinical staff attrition or sharp medical supply cost inflation elevates fixed operating expenditure. - Self-Funding Expansion Cash Profile: Major greenfield expansion outlays exceed operating cash generation and trigger renewed leverage. - Minimal Working Capital and Cash Collection Cycles: Institutional or government scheme billing rises to a substantial portion of revenue with delayed reimbursement cycles. ### The main risks

- Single-Cluster Geographic Concentration: Revenue and operational infrastructure are concentrated in Coimbatore, exposing cash flow to regional events. ⚠ estimate
- Regulatory Pricing Caps on Procedures and Consumables: Government interventions on healthcare package rates, stent prices, or insurance billing caps could compress margins. ⚠ estimate
- Capital Intensity of Future Hospital Expansion: Greenfield hospital expansions outside Coimbatore could incur extended gestation periods and drag return ratios. ⚠ estimate
- : Combined FII and DII shareholding of 5.13% and lack of shareholder concalls result in lower public market scrutiny. ⚠ estimate

(Our read after the April to June 2026 results, written 22 August 2026.)

## What to watch in Kovai Medical Center & Hospital's next results? When Kovai Medical Center & Hospital reports July to September 2026, these are the 5 checks that show whether the story is still on course. First: Quarterly operating profit margin declining below 26.0% or profit growth dropping below 10% on a year earlier. | What to check | Why |
| --- | --- |
| Quarterly operating profit margin declining below 26.0% or profit growth dropping below 10% on a year earlier. |  |
| A sequential drop in quarterly revenue or footfalls persisting across two consecutive quarters. | Single-Cluster Geographic Concentration |
| New state or national regulatory orders capping private tertiary hospital treatment tariffs. | Regulatory Pricing Caps on Procedures and Consumables |
| Annual capital spending announcements exceeding 400 Cr funded primarily via new debt issuances. | Capital Intensity of Future Hospital Expansion |
| Promoter shareholding reduction or institutional outflows exceeding 2.0% of total shares. |  |

## Which stock lists is Kovai Medical Center & Hospital on? Kovai Medical Center & Hospital is not on any of our India lists this week. ## Is Kovai Medical Center & Hospital profitable? Kovai Medical Center & Hospital Ltd earned ₹69.0 Cr of net profit in the Jun 2026 quarter, +21.1% on the same quarter a year earlier. That is the 12th quarter in a row of profit growth. Full-year FY26 profit was ₹244 Cr. Over 10 years profit has grown 19.8% a year on average. That is 16.0% of the quarter's revenue. The same quarter a year earlier earned ₹57.0 Cr. For the full year, FY26 profit was ₹244 Cr (+16.7% on the year before). Why profit moved: revenue changed +15.2% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +15.8% and revenue +14.9%. Profit and revenue are moving at about the same pace. FY26-Q4. revenue ₹414 Cr and profit ₹63 Cr as reported. FY27-Q1. revenue ₹431 Cr and profit ₹69 Cr as reported. Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters. ## How much revenue does Kovai Medical Center & Hospital make, and is it growing? Kovai Medical Center & Hospital Ltd reported ₹431 Cr of revenue in the Jun 2026 quarter, +15.2% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 10 years it has grown 13.1% a year on average. The last full year, FY26, came in at ₹1,586 Cr. Why this happened. Kovai Medical Center functions as the primary referral hub for tertiary healthcare in Coimbatore, Erode, and Tirupur districts. Inpatient volume expansion and specialty complexity supported revenue growth from 344 Cr in Q2 FY25 to 431 Cr in Q1 FY27. The last four reported quarters add to ₹1,644 Cr. FY26 revenue was ₹1,586 Cr, +15.7% on the year before. Recent pace: the last four quarters grew +14.9% on average, against 13.1% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +15.0%, against +14.2% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +15.8%, against +14.9% a year (stabilising). FY26-Q4. revenue ₹414 Cr and profit ₹63 Cr as reported. FY27-Q1. revenue ₹431 Cr and profit ₹69 Cr as reported. Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters. ## How much of every ₹100 of sales does Kovai Medical Center & Hospital keep? Kovai Medical Center & Hospital Ltd's operating margin was 29.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between 20.0% and 29.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +0.4 percentage points on the year while gross margin changed −0.7 points. So the gain came mostly from the gross margin, which means input costs and prices charged. FY26-Q4. revenue ₹414 Cr and profit ₹63 Cr as reported. FY27-Q1. revenue ₹431 Cr and profit ₹69 Cr as reported. Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters. ## Is Kovai Medical Center & Hospital's profit turning into cash? Over the last 3 years, 164% of Kovai Medical Center & Hospital Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹362 Cr of operating cash against ₹244 Cr of profit. After ₹281 Cr of spending on assets, ₹81.0 Cr was left over as free cash. Why this happened. Direct cash and insurance-counter settlement models limit trade receivables. Debtor days stood at 9 days in FY26, supporting a working capital cycle of -58 days when factoring payables and customer advances. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 164% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: the bigger use of cash is spending on new assets, at 2.7× depreciation over three years. The next section checks what that spending is building. ## Where does Kovai Medical Center & Hospital's cash go? Kovai Medical Center & Hospital Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 6 days in FY26, up from −2 days in FY21. It spent ₹797 Cr on assets over the last 3 years. Customers take 9 days to pay, and stock sits for 17 days on average. At FY26 sales of ₹1,586 Cr, each day of that cycle ties up about ₹4.3 Cr, so roughly ₹26.0 Cr is tied up in the business at any time. FY26: customers took 9 days to pay and stock sat for 17 days, about 0.6 months of sales sitting as stock, for a full cycle of 6 days, longer than FY21's −2. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 17 days. Customers pay about 9 days after that. Suppliers are paid at 20 days. Together that makes the 6-day cycle. Spending on assets: ₹797 Cr over the last 3 years, against ₹299 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹135 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Kovai Medical Center & Hospital's P/E ratio, and how does it compare with its own history? Kovai Medical Center & Hospital Ltd's P/E is 25.1×, near the high end of its own history: higher than 73% of past readings. Its usual P/E (the middle reading) is 19.8×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +17.0% while the price moved −8.0%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +28.9% a year; about +18.1% a year came from earnings growth and about +10.8 percentage points from the multiple (the market paying more); over 10 years the price moved +22.2% a year; about +17.5% a year came from earnings growth and about +4.7 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## What growth does the Kovai Medical Center & Hospital share price assume? Worked out from its price on 27 August 2026, Kovai Medical Center & Hospital Ltd's share price assumed profit growth of about 14.8% a year. Over the past 10 years its profit actually grew 19.8% a year. Today its P/E is 25.1×, higher than 73% of its own last 11 years. This is a one-day reading, taken on 27 August 2026. Every other number on this page, the multiple included, uses the latest price as of 3 November 2026. A higher price assumes more growth and a lower price less, so it changes whenever the price changes, and this page does not update it between measurements. ## Is the Kovai Medical Center & Hospital business getting better or worse? Kovai Medical Center & Hospital Ltd's business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 22.8%. This is based on 12 quarters of 4 measures. Why it matters: steady growth with healthy returns is how a business compounds over time. ## What is the Kovai Medical Center & Hospital story, and has it been checked? Kovai Medical Center & Hospital Ltd's story is not scored yet against the checks our research set on 22 August 2026. Where it sits in its own cycle: MID EXPANSION. Our read, 22 August 2026. From the numbers. The pe pb cycle engine…

From the price. Price stage 2, week 16, below its 200-day line, relative strength rising. From the research. Where they disagree. Operating cycle progression is in mid-expansion, with annual ROCE stable at 23% and quarterly top-line expansion staying steady at 14% to 16% YoY. What is proven. What is not proven yet. A sustained deterioration in quarterly operating profit margin below 24% combined with debtor days expanding beyond 20 days or negative free cash flow for three consecutive quarters without planned capacity commissioning. What would change our mind. A sustained deterioration in quarterly operating profit margin below 24% combined with debtor days expanding beyond 20 days or negative free cash flow for three consecutive quarters without planned capacity commissioning. The test written in advance. A sustained deterioration in quarterly operating profit margin below 24% combined with debtor days expanding beyond 20 days or negative free cash flow for three consecutive quarters without planned capacity commissioning. Measured by: the thesis as written as stated by the next result. The test written in advance. The test written in advance. Single-Cluster Geographic Concentration. Measured by: Single-Cluster Geographic Concentration A sequential drop in quarterly revenue or footfalls persisting across two consecutive quarters. by the next result. What the company does. Revenue expanded from 690 Cr in FY21 to 1,586 Cr in FY26 while operating margins remained stable between 27% and 30% across 12 consecutive quarters. Self-funded capital expenditure of 1,004 Cr over 5 years backed by 1,041 Cr cumulative 3-year operating cash flow while reducing borrowings from 550 Cr in FY22 to 403 Cr in FY26. What the surface reading misses. The surface reading is: Q1 FY27 revenue reached 431 Cr with net profit of 69 Cr, reflecting continued quarterly scale. The research reads it further: Revenue expanded 15.2% YoY and operating margin reached 29%, showing fixed-bed operational leverage with no margin erosion despite higher depreciation (32 Cr). What the surface reading misses. The surface reading is: Full-year FY26 delivered 1,586 Cr top-line and 244 Cr PAT, sustaining long-term double-digit expansion. The research reads it further: Operating profit of 445 Cr maintained a stable 28% OPM, translating top-line growth of 15.7% into 16.7% PAT growth without requiring margin spikes. Lever 2 · Value-added mix: building. Regional dominance in Coimbatore drives inpatient volumes and surgical procedure mix across multi-specialty departments. What proves it keeps working: Tertiary Care Demand Density in Western Tamil Nadu. It stops working if New corporate hospital chains construct competing tertiary facilities in Coimbatore and dilute local patient market share. Lever 1 · Operating leverage: building. Fixed medical infrastructure and teaching hospital assets convert incremental volume to profit at 27% to 29% operating margins. What proves it keeps working: Operating Leverage from Medical College and Bed Additions. It stops working if Clinical staff attrition or sharp medical supply cost inflation elevates fixed operating expenditure. Lever 4 · Paying down debt: building. 3-year cumulative operating cash flow of 1,041 Cr fully funds ongoing brownfield projects and allows debt reduction. What proves it keeps working: Self-Funding Expansion Cash Profile. It stops working if Major greenfield expansion outlays exceed operating cash generation and trigger renewed leverage. Sources: our stock research file (22 August 2026) · quarterly results through Jun 2026. The story check is re-scored every results season; the record below never changes. ## What is Kovai Medical Center & Hospital management's track record? Margins held through the FY21 downturn, expansion was funded from cash, and borrowings fell while capacity was added. ### Regulatory and governance record

No company-specific SEBI, CBI or ED action or material penalty surfaced; filings were routine. 0% Promoter shares pledged

Sources:

- [moneyworks4me.com](https://www.moneyworks4me.com/indianstocks/small-cap/healthcare/hospital-healthcare-services/kovai-medical-center/company-info)
- [economictimes.indiatimes.com](https://economictimes.indiatimes.com/kovai-medical-center-and-hospital-ltd/stocksupdate/companyid-13465.cms)

(Checked 30 August 2026.)

## How much does Kovai Medical Center & Hospital earn on its capital? Kovai Medical Center & Hospital Ltd earned a ROCE of 23% in FY26. That is up from a low of 13% in FY21. Its return on capital used (ROIC) is 6.9 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 15.4% net margin and 0.77× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 15.4% net margin × 0.77× asset turnover × 1.57× leverage (assets divided by equity) ≈ 18.6% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 18.9% − 12.0% = +6.9 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value. ## Does Kovai Medical Center & Hospital have too much debt? Kovai Medical Center & Hospital Ltd has total debt of ₹403 Cr against shareholder equity of ₹1,319 Cr as of Jun 2026, so its debt is 0.31× its equity. Year by year, that ratio went from 0.90 in FY22 to 0.31 in FY26. Keep that borrowing in mind when reading the returns on this page. Why this happened. Under the capex inflection point framework, previous capital outlays for hospital beds and the KMCH Institute of Health Sciences are maturing into stable earning assets. Operating profit expanded from 96 Cr in Q2 FY25 to 124 Cr in Q1 FY27. ## What is the Kovai Medical Center & Hospital shareholding pattern? No group of Kovai Medical Center & Hospital Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved −0.1 points over the same period, to 4.3%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: +0.8 points over 8 quarters, to 1.2%; Domestic institutions: −0.1 points over 8 quarters, to 4.3%; Promoters: +0.0 points over 8 quarters, to 56.5%. ## How far is Kovai Medical Center & Hospital from balance-sheet trouble? For Kovai Medical Center & Hospital Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Kovai Medical Center & Hospital rank in its industry? 61.5 out of 100, rank 5 of 20 in Hospitals, with 96% of the evidence available. Kovai Medical Center & Hospital Ltd scores 61.5 out of 100 against the 20 companies it is compared with in Hospitals, ranking 5. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 18.8 + 19.1 + 8.9 + 14.7 = 61.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Kovai Medical Center & Hospital compared with? Kovai Medical Center & Hospital ranks 5 of 20 Hospitals companies on the 4-Factor Sector Score, with 61.5 out of 100. 1. [KMC Speciality Hospitals (India) Ltd](https://www.sectoralpha.in/stocks/kmc-speciality-hospitals-indialtd) KMCSHIL · breaking out · Sector-leading setup · 81% evidence 80.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.0/35 · Revenue 35.1% · Profit 100% · Operating margin change 6 points · 88% evidence Capital efficiency 23.1/25 · ROCE 26.2% · Operating margin 31% · 100% evidence Valuation 14.1/20 · P/E 43.4× · PEG 0.68 · 100% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 45.6% · 1 year 115.4% · 25% evidence · 5 of 5 weeks ahead Exact sum: 31 + 23.1 + 14.1 + 12.5 = 80.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Sakar Healthcare Ltd](https://www.sectoralpha.in/stocks/sakar-healthcare-ltd) SAKAR · leader · Most evidence points up · 100% evidence 68.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.5/35 · Revenue 47.5% · Profit 100% · Operating margin change 8 points · 100% evidence Capital efficiency 11.5/25 · ROCE 12.4% · Operating margin 28% · 100% evidence Valuation 11.1/20 · P/E 49× · PEG 1.05 · 100% evidence Relative strength 13.8/20 · Lead over its industry 41.8% · Lead over NIFTY 500 45.4% · 1 year 161.6% · 100% evidence · 12 of 12 weeks ahead Exact sum: 32.5 + 11.5 + 11.1 + 13.8 = 68.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Apollo Hospitals Enterprise Ltd](https://www.sectoralpha.in/stocks/apollo-hospitals-enterprise-ltd) APOLLOHOSP · turning · Most evidence points up · 78% evidence 68.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.0/35 · Revenue 17.2% · Profit 33.2% · Operating margin change 1 points · 83% evidence Capital efficiency 15.2/25 · ROCE 17.4% · Operating margin 16% · 76% evidence Valuation 12.7/20 · P/E 57.7× · PEG n/a · 50% evidence Relative strength 16.6/20 · Lead over its industry 6.6% · Lead over NIFTY 500 11.2% · 1 year 10% · 100% evidence · 4 of 12 weeks ahead Exact sum: 24 + 15.2 + 12.7 + 16.6 = 68.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Dr Agarwals Eye Hospital Ltd](https://www.sectoralpha.in/stocks/dr-agarwals-eye-hospital-ltd) DRAGARWQ · breaking out · Evidence leans up · 81% evidence 62.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 20.1% · Profit 31.6% · Operating margin change -2 points · 88% evidence Capital efficiency 17.4/25 · ROCE 17.2% · Operating margin 30% · 100% evidence Valuation 12.5/20 · P/E 33.7× · PEG 1.36 · 100% evidence Relative strength 11.6/20 · Lead over its industry n/a · Lead over NIFTY 500 9.2% · 1 year 0.8% · 25% evidence · 8 of 12 weeks ahead Exact sum: 21.1 + 17.4 + 12.5 + 11.6 = 62.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. Kovai Medical Center & Hospital Ltd this page KOVAI · breaking out · Evidence leans up · 96% evidence 61.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 15% · Profit 15.8% · Operating margin change 1 points · 88% evidence Capital efficiency 19.1/25 · ROCE 22.6% · Operating margin 29% · 100% evidence Valuation 8.9/20 · P/E 24.8× · PEG 2.01 · 100% evidence Relative strength 14.7/20 · Lead over its industry 1.9% · Lead over NIFTY 500 6.6% · 1 year -9.2% · 100% evidence · 10 of 12 weeks ahead Exact sum: 18.8 + 19.1 + 8.9 + 14.7 = 61.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [GPT Healthcare Ltd](https://www.sectoralpha.in/stocks/gpt-healthcare-ltd) GPTHEALTH · quiet · Evidence leans up · 81% evidence 61.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.4/35 · Revenue 18% · Profit 0% · Operating margin change 3 points · 88% evidence Capital efficiency 18.2/25 · ROCE 19.9% · Operating margin 19% · 100% evidence Valuation 18.5/20 · P/E 23× · PEG 0.94 · 100% evidence Relative strength 9.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -2.1% · 1 year -10.7% · 25% evidence · 4 of 12 weeks ahead Exact sum: 15.4 + 18.2 + 18.5 + 9.1 = 61.2 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 7. [Yatharth Hospital & Trauma Care Services Ltd](https://www.sectoralpha.in/stocks/yatharth-hospital-trauma-care-services-ltd) YATHARTH · breaking out · Evidence leans up · 78% evidence 57.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.4/35 · Revenue 43.9% · Profit 22.5% · Operating margin change -2 points · 83% evidence Capital efficiency 12.4/25 · ROCE 12.9% · Operating margin 23% · 76% evidence Valuation 6.7/20 · P/E 49.3× · PEG n/a · 50% evidence Relative strength 19.1/20 · Lead over its industry 17.1% · Lead over NIFTY 500 21.6% · 1 year 16.4% · 100% evidence · 10 of 12 weeks ahead Exact sum: 19.4 + 12.4 + 6.7 + 19.1 = 57.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Artemis Medicare Services Ltd](https://www.sectoralpha.in/stocks/artemis-medicare-services-ltd) ARTEMISMED · leader · Evidence leans up · 100% evidence 56.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.4/35 · Revenue 14.7% · Profit 20% · Operating margin change 0 points · 100% evidence Capital efficiency 12.8/25 · ROCE 14.6% · Operating margin 18% · 100% evidence Valuation 8.0/20 · P/E 39.7× · PEG 2.44 · 100% evidence Relative strength 16.7/20 · Lead over its industry 8.4% · Lead over NIFTY 500 12.9% · 1 year 18.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 19.4 + 12.8 + 8 + 16.7 = 56.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Indraprastha Medical Corporation Ltd](https://www.sectoralpha.in/stocks/indraprastha-medical-corporation-ltd) INDRAMEDCO · quiet · Evidence leans up · 85% evidence 51.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.3/35 · Revenue 10.8% · Profit 10.9% · Operating margin change 0 points · 100% evidence Capital efficiency 17.6/25 · ROCE 35.8% · Operating margin 19% · 100% evidence Valuation 13.2/20 · P/E 14.6× · PEG 1.47 · 100% evidence Relative strength 7.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -19.7% · 1 year -49.6% · 25% evidence · 0 of 12 weeks ahead Exact sum: 13.3 + 17.6 + 13.2 + 7.7 = 51.8 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 10. [Global Health Ltd](https://www.sectoralpha.in/stocks/global-health-ltd) MEDANTA · losing its lead · Evidence leans up · 96% evidence 50.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.5/35 · Revenue 21.3% · Profit 3.4% · Operating margin change -2 points · 88% evidence Capital efficiency 17.3/25 · ROCE 17.4% · Operating margin 22% · 100% evidence Valuation 5.5/20 · P/E 59.7× · PEG 9.11 · 100% evidence Relative strength 14.2/20 · Lead over its industry 3.7% · Lead over NIFTY 500 8.1% · 1 year -3.1% · 100% evidence · 8 of 12 weeks ahead Exact sum: 13.5 + 17.3 + 5.5 + 14.2 = 50.5 · What this means: Relative strength against the index is 8.1%, and revenue and profit growth are weak. 11. [Rainbow Childrens Medicare Ltd](https://www.sectoralpha.in/stocks/rainbow-childrens-medicare-ltd) RAINBOW · quiet · Evidence leans up · 100% evidence 50.3 out of 100 Growth Capital Valuation Relative
12. [Max Healthcare Institute Ltd](https://www.sectoralpha.in/stocks/max-healthcare-institute-ltd) MAXHEALTH · quiet · Evidence leans down · 85% evidence 48.7 out of 100 Growth Capital Valuation Relative
13. [Fortis Healthcare Ltd](https://www.sectoralpha.in/stocks/fortis-healthcare-ltd) FORTIS · basing · Evidence leans down · 78% evidence 45.1 out of 100 Growth Capital Valuation Relative
14. [Shalby Ltd](https://www.sectoralpha.in/stocks/shalby-ltd) SHALBY · quiet · Evidence leans down · 63% evidence 42.0 out of 100 Growth Capital Valuation Relative
15. [Narayana Hrudayalaya Ltd](https://www.sectoralpha.in/stocks/narayana-hrudayalaya-ltd) NH · quiet · Evidence leans down · 78% evidence 40.8 out of 100 Growth Capital Valuation Relative
16. [Aster DM Quality Care Ltd](https://www.sectoralpha.in/stocks/aster-dm-quality-care-ltd) ASTERDM · quiet · Evidence leans down · 96% evidence 35.2 out of 100 Growth Capital Valuation Relative
17. [Krishna Institute of Medical Sciences Ltd](https://www.sectoralpha.in/stocks/krishna-institute-of-medical-sciences-ltd) KIMS · quiet · Most evidence points down · 78% evidence 34.8 out of 100 Growth Capital Valuation Relative
18. [Jupiter Life Line Hospitals Ltd](https://www.sectoralpha.in/stocks/jupiter-life-line-hospitals-ltd) JLHL · quiet · Most evidence points down · 100% evidence 33.0 out of 100 Growth Capital Valuation Relative
19. [Healthcare Global Enterprises Ltd](https://www.sectoralpha.in/stocks/healthcare-global-enterprises-ltd) HCG · quiet · Most evidence points down · 71% evidence 31.1 out of 100 Growth Capital Valuation Relative
20. [Manipal Health Enterprises Ltd](https://www.sectoralpha.in/stocks/manipal-health-enterprises-ltd) MANIPALHOS · Too little evidence to rank firmly · 38% evidence 42.4 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Hospitals](https://www.sectoralpha.in/sectors/hospitals), all 20 compared on one page. ## Which companies are close to Kovai Medical Center & Hospital in size? Kovai Medical Center & Hospital is the 13th largest of 20 Hospitals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Yatharth Hospital & Trauma Care Services, Healthcare Global Enterprises and Jupiter Life Line Hospitals. Just below it: Artemis Medicare Services, Indraprastha Medical Corporation and Dr Agarwals Eye Hospital. ### Hospitals companies close in size

1. [Yatharth Hospital & Trauma Care Services Ltd](https://www.sectoralpha.in/stocks/yatharth-hospital-trauma-care-services-ltd) ₹8,931 crore
2. [Healthcare Global Enterprises Ltd](https://www.sectoralpha.in/stocks/healthcare-global-enterprises-ltd) ₹8,742 crore
3. [Jupiter Life Line Hospitals Ltd](https://www.sectoralpha.in/stocks/jupiter-life-line-hospitals-ltd) ₹8,430 crore
4. Kovai Medical Center & Hospital Ltd ₹6,363 crore
5. [Artemis Medicare Services Ltd](https://www.sectoralpha.in/stocks/artemis-medicare-services-ltd) ₹4,642 crore
6. [Indraprastha Medical Corporation Ltd](https://www.sectoralpha.in/stocks/indraprastha-medical-corporation-ltd) ₹2,802 crore
7. [Dr Agarwals Eye Hospital Ltd](https://www.sectoralpha.in/stocks/dr-agarwals-eye-hospital-ltd) ₹2,570 crore

[All 20 Hospitals companies, largest first](https://www.sectoralpha.in/sectors/hospitals#all-companies)

### Companies close in size in other industries

1. [Gujarat Ambuja Exports Ltd](https://www.sectoralpha.in/stocks/gujarat-ambuja-exports-ltd) ₹6,388 crore · Agricultural Processing - Maize
2. [Zee Entertainment Enterprises Ltd](https://www.sectoralpha.in/stocks/zee-entertainment-enterprises-ltd) ₹6,378 crore · Entertainment & Media
3. Kovai Medical Center & Hospital Ltd ₹6,363 crore
4. [Gokul Agro Resources Ltd](https://www.sectoralpha.in/stocks/gokul-agro-resources-ltd) ₹6,329 crore · Edible Oils, Agro Processing
5. [Jyothy Labs Ltd](https://www.sectoralpha.in/stocks/jyothy-labs-ltd) ₹6,313 crore · FMCG - Personal Care

## What else do people ask about Kovai Medical Center & Hospital? ### What is Kovai Medical Center & Hospital's share price today? Kovai Medical Center & Hospital Ltd's share price is ₹5,887.50, −8.0% over the past year. The whole company is worth ₹6,441 Cr on the market. In the last 52 weeks it traded between ₹5,098 to ₹6,233; today it is 70% of the way up from the low, 1.0% above its 200-day average (as of 3 November 2026). ### What were Kovai Medical Center & Hospital's latest quarterly results? Kovai Medical Center & Hospital Ltd reported revenue of ₹431 Cr and net profit of ₹69.0 Cr for the Jun 2026 quarter. Revenue rose 15.2% and profit rose 21.1% compared with a year earlier. Earnings per share were ₹63.14 (as of 3 November 2026). ### What is Kovai Medical Center & Hospital's market cap? Kovai Medical Center & Hospital Ltd's market capitalisation is ₹6,441 Cr at a share price of ₹5,887.50. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Kovai Medical Center & Hospital performing? Kovai Medical Center & Hospital Ltd's share price has been rising for 16 weeks. In its latest quarter, revenue rose 15.2% and profit rose 21.1% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 11 weeks running (as of 3 November 2026). ### Will Kovai Medical Center & Hospital's share price go up? This page does not forecast Kovai Medical Center & Hospital Ltd's share price. What it shows instead: the share price is ₹5,887.50, and it has been rising for 16 weeks. Its P/E of 25.1× is higher than 73% of its own last 11 years (as of 3 November 2026). ### Who owns Kovai Medical Center & Hospital? Promoters own 56.5% of Kovai Medical Center & Hospital Ltd, foreign institutions 1.2%, domestic institutions 4.3% and the public 37.9% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Where is Kovai Medical Center & Hospital in its business cycle? Kovai Medical Center & Hospital Ltd's FY26 operating margin was 28.0%, against a 13-year range of 20.0% to 29.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 29.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Kovai Medical Center & Hospital story? The main question: yearly earnings per share moved +17.0% while the share price moved −8.0%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Kovai Medical Center & Hospital a stock worth studying right now? What the numbers show: Kovai Medical Center & Hospital Ltd's earnings have grown faster than its share price. Earnings per share grew +17.0% in a year while the price moved −8.0%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Kovai Medical Center & Hospital share price forecast for 2026? What is changing at Kovai Medical Center & Hospital, from the latest results and calls: tertiary care demand density in western tamil nadu, operating leverage from medical college and bed additions and self-funding expansion cash profile. What would change the story: A sustained deterioration in quarterly operating profit margin below 24% combined with debtor days expanding beyond 20 days or negative free cash flow for three consecutive quarters without planned capacity commissioning. ### Where does this page get Kovai Medical Center & Hospital's management information? From Kovai Medical Center & Hospital's results calls, its filings and public records on governance, each dated on the page. Management’s plans are shown as plans, never as results. This is research, not advice. We’re not SEBI-registered.